Pages that link to "Q39398830"

The following pages link to Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer (Q39398830):

Displaying 25 items.

• Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells (Q26766065) (← links)
• The role of CD44 in epithelial-mesenchymal transition and cancer development (Q26771509) (← links)
• Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers (Q26822406) (← links)
• The CD44(high) tumorigenic subsets in lung cancer biospecimens are enriched for low miR-34a expression (Q31137385) (← links)
• Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review (Q34028901) (← links)
• Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential (Q34438815) (← links)
• B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells (Q35748841) (← links)
• CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer (Q36094140) (← links)
• Effect of alendronate sodium on the expression of mesenchymal-epithelial transition markers in mice with liver fibrosis (Q36472101) (← links)
• MIA PaCa-2 and PANC-1 - pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors (Q36588574) (← links)
• TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis (Q36737131) (← links)
• Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors (Q37017121) (← links)
• The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis (Q37564029) (← links)
• Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer (Q37573308) (← links)
• Membranous CD24 drives the epithelial phenotype of pancreatic cancer. (Q37580189) (← links)
• Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies (Q37610799) (← links)
• The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma (Q37729238) (← links)
• Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer (Q39039925) (← links)
• The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation. (Q41712337) (← links)
• Antitumor effects of matrine on cancer stem like cells isolated from the human liver cancer SMMC-7721 cell line (Q50024794) (← links)
• MicroRNA-328 inhibits migration and epithelial-mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells. (Q55394876) (← links)
• Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway (Q57466751) (← links)
• Anti-fibrotic impact of Carvedilol in a CCl-4 model of liver fibrosis via serum microRNA-200a/SMAD7 enhancement to bridle TGF-β1/EMT track (Q58698696) (← links)
• Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events (Q88149003) (← links)
• Redox regulation in tumor cell epithelial-mesenchymal transition: molecular basis and therapeutic strategy (Q89700531) (← links)